• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用E试验研究具有临床意义的酵母分离株对五种抗真菌药物的敏感性。

Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.

作者信息

Linares M J, Muñoz J F, Solís F, Rodríguez F C, Valero A, Casal M

机构信息

Department of Microbiology, Faculty of Medicine, University of Córdoba, Córdoba.

出版信息

Rev Esp Quimioter. 1998 Mar;11(1):64-9.

PMID:9795292
Abstract

The E test is a quantitative technique for determining antimicrobial susceptibility; it is based on the diffusion of a stable predetermined gradient of a specific antifungal agent along an inert plastic strip which is applied to a solid culture medium. The E test is an alternative method for determining inhibitory concentrations of antimicrobial agents. The aim of the present study was to determine the in vitro susceptibility of different yeasts to 5 antifungal agents using the E test. The antifungal susceptibility of 87 strains, 73 of which were yeasts obtained from clinical samples, 11 were Prototheca strains and 3 controls, were examined using a gradient diffusion technique (E test). Of these isolates, 13% of Candida albicans were resistant to flucytosine, and 20%, 17% and 33% showed resistance to ketoconazole, itraconazole and fluconazole, respectively. All Candida krusei isolates showed resistance to flucytosine and fluconazole. The Candida parapsilosis and Candida tropicalis strains all presented in vitro susceptibility to all the agents tested. Prototheca strains were only susceptible in vitro to amphotericin B. It was found that the E test was easy to perform, and provided MIC values similar to those obtained with other well documented techniques. It was therefore concluded that the E test could be implemented as a standard procedure in clinical mycology laboratories.

摘要

E试验是一种用于确定抗菌药物敏感性的定量技术;它基于一种特定抗真菌药物的稳定预定梯度沿着一条应用于固体培养基的惰性塑料条扩散。E试验是确定抗菌药物抑制浓度的另一种方法。本研究的目的是使用E试验确定不同酵母菌对5种抗真菌药物的体外敏感性。使用梯度扩散技术(E试验)检测了87株菌株的抗真菌药敏性,其中73株是从临床样本中获得的酵母菌,11株是原藻菌株,3株为对照菌株。在这些分离株中,13%的白色念珠菌对氟胞嘧啶耐药,20%、17%和33%分别对酮康唑、伊曲康唑和氟康唑耐药。所有克鲁斯念珠菌分离株均对氟胞嘧啶和氟康唑耐药。近平滑念珠菌和热带念珠菌菌株对所有测试药物均表现出体外敏感性。原藻菌株仅在体外对两性霉素B敏感。研究发现,E试验易于操作,且提供的最低抑菌浓度(MIC)值与其他有充分文献记载的技术所获得的值相似。因此得出结论,E试验可作为临床真菌学实验室的标准程序实施。

相似文献

1
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.使用E试验研究具有临床意义的酵母分离株对五种抗真菌药物的敏感性。
Rev Esp Quimioter. 1998 Mar;11(1):64-9.
2
[Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].[使用 Sensititre 系统测定临床重要酵母菌的体外抗真菌药敏性]
Rev Esp Quimioter. 1999 Jun;12(2):126-35.
3
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.马来西亚新型隐球菌格鲁比变种和加蒂隐球菌临床分离株对五种抗真菌药物的体外敏感性
Mycoses. 2006 Jul;49(4):324-30. doi: 10.1111/j.1439-0507.2006.01242.x.
4
[Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].[血液和脑脊液中酵母分离株抗真菌药敏试验的微量肉汤稀释法研究]
Rinsho Byori. 1996 Apr;44(4):373-8.
5
Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.Sensititre YeastOne与NCCLS M27A方案及E试验用于酵母抗真菌药敏试验的比较评估
Mycoses. 2004 Oct;47(9-10):397-401. doi: 10.1111/j.1439-0507.2004.01013.x.
6
[Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].[比色肉汤微量稀释抗真菌药敏试验的多中心评估]
Rinsho Byori. 1997 Feb;45(2):190-9.
7
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].[使用E试验检测暗色丝孢真菌的体外抗真菌药敏性]
Rev Esp Quimioter. 2001 Jun;14(2):191-7.
8
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.三级医疗癌症中心的念珠菌血症:体外药敏性及其与初始抗真菌治疗结果的关联
Medicine (Baltimore). 2003 Sep;82(5):309-21. doi: 10.1097/01.md.0000091182.93122.8e.
9
Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.台湾念珠菌属、新型隐球菌及曲霉菌属临床分离株的抗真菌药敏性:2003年台湾多中心抗菌药物耐药性监测计划数据
Antimicrob Agents Chemother. 2005 Feb;49(2):512-7. doi: 10.1128/AAC.49.2.512-517.2005.
10
In vitro susceptibility of Cryptococcus neoformans clinical isolates from Egypt to seven antifungal drugs.埃及新型隐球菌临床分离株对七种抗真菌药物的体外敏感性
Mycoses. 2005 Sep;48(5):327-32. doi: 10.1111/j.1439-0507.2005.01137.x.

引用本文的文献

1
Lethal systemic and brain infection caused by algae in a patient with acute myeloid leukemia.一名急性髓系白血病患者因藻类感染导致致命的全身及脑部感染。
Med Mycol Case Rep. 2021 Jan 28;32:17-20. doi: 10.1016/j.mmcr.2021.01.004. eCollection 2021 Jun.
2
Human protothecosis.人类原藻病
Clin Microbiol Rev. 2007 Apr;20(2):230-42. doi: 10.1128/CMR.00032-06.
3
In vitro activity of voriconazole against Prototheca wickerhamii: comparative evaluation of sensititre and NCCLS M27-A2 methods of detection.伏立康唑对威克海默原藻的体外活性:Sensititre法与NCCLS M27 - A2检测方法的比较评估
J Clin Microbiol. 2005 May;43(5):2520-2. doi: 10.1128/JCM.43.5.2520-2522.2005.
4
Comparison of two microdilution methods for testing susceptibility of Candida spp. to voriconazole.两种微量稀释法检测念珠菌属对伏立康唑敏感性的比较。
J Clin Microbiol. 2004 Feb;42(2):899-902. doi: 10.1128/JCM.42.2.899-902.2004.